Egle Ramelyte

20PUBLICATIONS

66CO-AUTHORS

Medical molecular engineering of nucleic acids and proteinsTumour immunologyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|Jul 13, 2026

An anti-PMEL antibody-drug conjugate with a G<sub>q/1</sub><sub>1</sub> inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial.

|Jun 09, 2026

Depicting the Immunological Landscape of Basal Cell Carcinoma Subtypes.

|Apr 27, 2026

Re-Exposure of a PD-1 Inhibitor After Previous Immune-Related Adverse Events.

|Mar 28, 2026

Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma.

Andrew E Quacoe, Sandra N Freiberger, Mitchell P Levesque

|Feb 25, 2026

Safety of Multi-Omics-Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort Analysis.

Benedict Gosztonyi, Tarun Mehra, Gabriele Gut

|Jan 10, 2026

Neoadjuvant Therapy in Resectable Advanced Melanoma: Swiss Real-World Data.

Ann-Kathrin Blumenröther, Yongxing Fang, Tamara El Saadany

Pageof 4

Frequent Collaborators

16 joint publications

Reinhard Dummer

Mitchell P Levesque

Patrick Turko

Sandra N Freiberger

M C Nägeli

Amélie Ciernik

Julia M Martínez-Gómez

2 joint publications

Kamaneh Montazeri

2 joint publications

Johanna Mangana

2 joint publications

Ramon Staeger

Frequent Collaborators

16 joint publications

Reinhard Dummer

8 joint publications

Mitchell P Levesque

3 joint publications

Patrick Turko

3 joint publications

Sandra N Freiberger